254 matches for your search in the start-up spotlight
rss
More hope for pregnancy: Ovo Labs secures 4 million pounds in start-up capital
05-May-2025
Founded in January 2025, Ovo Labs is a biotech company that has emerged from the Max Planck Institute (MPI) for Multidisciplinary Sciences in Göttingen (Germany). The company develops novel therapeutics to improve the quality of human eggs. The active compounds are designed to help women remain ...
NMI, TU Darmstadt and Black Drop develop improved bioink
29-Apr-2025
How can we 3D print tissues that mimic the complex anatomy of natural body tissue as closely as possible? 3D bioprinting is a great hope in the field of regenerative medicine to produce miniaturized tissues and organ precursors with biological functionality. Today, however, scientists are still ...
Four Universities and Futury Launch the Future Factory
31-Mar-2025
The Rhine-Main startup ecosystem is gaining momentum: Four leading universities – Goethe University Frankfurt, Johannes Gutenberg University Mainz, Technical University of Darmstadt, and Frankfurt School of Finance & Management – together with Futury, are launching the Future Factory, a ...
Start-up prize for "EmbryoNet AI Technologies"
25-Mar-2025
Using artificial intelligence to revolutionize drug development is the aim of the start-up "EmbryoNet AI Technologies" led by Konstanz biologist Patrick Müller. Müller and his team have now been awarded the start-up prize by the Federal Ministry for Economic Affairs and Climate Action (BMWK) for ...
Tumour-on-chip model supports preclinical drug development on pancreatic cancer
10-Mar-2025
The biotech company Dynamic42, a specialist in organ-on-chip technology, has made a significant advance in pancreatic cancer drug research in collaboration with the research team of Prof. Dr. Nicole Teusch at the Institute of Pharmaceutical Biology and Biotechnology at Heinrich Heine University ...
"EG 427 has the potential to significantly advance the applications of genetic medicine through highly targeted delivery and local administration"
04-Mar-2025
EG 427, a biotechnology company leading the development of pinpoint genetic medicines for prevalent chronic diseases in neurology, announced the successful closing of a €27 million Series B financing round co-led by Andera Partners and Bpifrance - as part of the InnoBio investment strategy. “The ...
03-Mar-2025
Improving treatment recommendations for colorectal cancer patients: This is the aim of a collaborative project between the University of Bonn, the company ESQlabs and the University Hospital Bonn (UKB), funded by the Federal Ministry of Education and Research. "ISPOT-K" combines organoids derived ...
4Tissue appoints Dr. Katleen Verleysen as independent chair of the board.
27-Feb-2025
4Tissue, a pioneer in biotechnology that is revolutionizing regenerative medicine, has successfully completed an additional €1.5M funding round, consisting of €1M in equity investments and additional grants. This funding will support the further development of the company’s groundbreaking ...
Project receiving 800,000 euros from the biomedical start-up incubator IBT Lower Saxony
24-Feb-2025
MHH project LuFex aims to develop a new inhalative treatment with a plant-based anti-fibrosis drug and is receiving 800,000 euros from the biomedical start-up incubator IBT Lower Saxony. Tissue damage can affect many organs and is responsible for about half of all deaths in industrialised ...
Drug candidate AC102 in the clinical phase
19-Feb-2025
There is currently no drug approved worldwide for the treatment of sudden hearing loss. However, preclinical and clinical phase-1-studies with the innovative drug candidate AC102 have been promising. AudioCure Pharma, a Berlin-based start-up supported by investors, is driving forward research and ...
